CIK: 1662521 - Address: C/O Halozyme Therapeutics, Inc., 12390 El Camino Real, San Diego, CA 92130
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/2/26 16:42
7/1/26
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagConnaughton BernadetteCADS-12576.710-2-442D
6/2/26 17:20
6/1/26
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagConnaughton BernadetteCADS-10866.210-2-444D
5/5/26 17:05
5/1/26
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagConnaughton BernadetteCADS-10363.480-2-438D
1/6/26 18:55
1/5/26
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagConnaughton BernadetteCADS-14170.250-2-540D
12/1/25 19:50
12/1/25
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagConnaughton BernadetteCADS-5971.600-1-242D
11/12/25 17:58
11/10/25
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagConnaughton BernadetteCADS-13768.480-2-443D
10/1/25 18:29
10/1/25
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagConnaughton BernadetteCADS-15075.240-2-445D
9/2/25 20:11
9/2/25
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagConnaughton BernadetteCADS-29573.680-4-847D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact